跳至主要内容
临床试验/NCT00469001
NCT00469001已完成不适用

Phase 1 Study of Using BNP as Guided Parameter in Treatment HF

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
108
试验地点
1

研究概览

简要总结

To use continuous measurement of NT Pro BNP level as guide in therapy patients with CHF.

详细描述

Group of 100 patients with CHF, NYHA II-IY will be followed for 1 years in outpatient clinic of our hospital for hospitalization, death, 6 min walking protocol, number of decompensation as a primary end point. 50 patients will be treated according usual practice in outpatient clinics and in 50 patients will be additionally used level of NT Pro BNP as additional parameter.If level NT Pro BNP will be goes down will not be changes in treatment regiment. If level of NT Pro BNP will be increased treatment will be intensified.At the end of 1 year follow up we will compare the result of two strategies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient older 18 y.old with CHF NYHA II-IY.

排除标准

  • All conditions with life expectancy less than 2 years.

研究者

申办方类型
Other Gov

研究点 (1)

Loading locations...

相似试验